/LFST

LFST Stock - LifeStance Health Group, Inc.

Q: What is the analyst price target for LFST?

Analyst price target information is not currently available for LFST.

Q: What is LFST's market cap?

Market capitalization information is not currently available for LFST.

Healthcare|Medical - Care Facilities|NASDAQ

$7.25-2.82%

$0.21 (-2.82%) • Jan 13

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

High Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+22.5%upside

Target: $8.88

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for LFST

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.11

52W High$8.29

52W Low$3.74

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.25B	$1.06B	$859.54M	$667.51M	$377.22M
Gross Profit	$402.40M	$302.10M	$237.02M	$201.51M	$134.32M
Gross Margin	32.2%	28.6%	27.6%	30.2%	35.6%
Operating Income	$-31,613,000	$-189,134,000	$-210,174,000	$-286,353,000	$15.44M
Net Income	$-57,443,000	$-186,262,000	$-215,564,000	$-307,197,000	$-38,070,000
Net Margin	-4.6%	-17.6%	-25.1%	-46.0%	-10.1%
EPS	$-0.15	$-0.51	$-0.61	$-1.05	$-0.83

Company Overview

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.

Visit Website

Earnings History & Surprises

LFST

Beat Rate

56%

Last 18 quarters

Avg Surprise

+0.8%

EPS vs Estimate

Beats / Misses

10/7

1 met exactly

Latest EPS

$0.00

Q4 2025

EPS Surprise History

Q1 24

-33.3%

$-0.12vs$-0.09

Q2 24

+33.3%

$-0.06vs$-0.09

Q3 24

+14.3%

$-0.06vs$-0.07

Q4 24

+71.4%

$-0.02vs$-0.07

Q1 25

+50.0%

$-0.02vs$-0.04

Q2 25

+104.6%

$0.00vs$-0.04

Q3 25

+66.7%

$-0.01vs$-0.03

Q4 25

+127.7%

$0.00vs$-0.01

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Feb 26, 2026	—	—	—	—
Q4 2025	Nov 6, 2025	$-0.01	$0.00	+127.7%	✓ BEAT
Q3 2025	Aug 7, 2025	$-0.03	$-0.01	+66.7%	✓ BEAT
Q2 2025	May 7, 2025	$-0.04	$0.00	+104.6%	✓ BEAT
Q1 2025	Feb 27, 2025	$-0.04	$-0.02	+50.0%	✓ BEAT
Q4 2024	Nov 7, 2024	$-0.07	$-0.02	+71.4%	✓ BEAT
Q3 2024	Aug 8, 2024	$-0.07	$-0.06	+14.3%	✓ BEAT
Q2 2024	May 9, 2024	$-0.09	$-0.06	+33.3%	✓ BEAT
Q1 2024	Feb 28, 2024	$-0.09	$-0.12	-33.3%	✗ MISS
Q4 2023	Nov 8, 2023	$-0.07	$-0.17	-142.9%	✗ MISS
Q3 2023	Aug 9, 2023	$-0.09	$-0.13	-44.4%	✗ MISS
Q2 2023	May 10, 2023	$-0.11	$-0.09	+18.2%	✓ BEAT
Q1 2023	Mar 8, 2023	$-0.13	$-0.13	0.0%	= MET
Q4 2022	Nov 8, 2022	$-0.15	$-0.11	+26.7%	✓ BEAT
Q3 2022	Aug 9, 2022	$-0.12	$-0.19	-58.3%	✗ MISS
Q2 2022	May 9, 2022	$-0.15	$-0.18	-20.0%	✗ MISS
Q1 2022	Mar 10, 2022	$-0.37	$-0.32	+13.5%	✓ BEAT
Q4 2021	Nov 8, 2021	$-0.27	$-0.35	-29.6%	✗ MISS
Q3 2021	Aug 11, 2021	$-0.06	$-0.17	-183.3%	✗ MISS
Q2 2021	Jun 1, 2021	—	$-0.02	—	—

Frequently Asked Questions about LFST

What is LFST's current stock price?

LifeStance Health Group, Inc. (LFST) is currently trading at $7.25 per share. The stock has moved -2.82% today.

What is the analyst price target for LFST?

The average analyst price target for LFST is $8.88, based on 1 analyst.

What sector is LifeStance Health Group, Inc. in?

LifeStance Health Group, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NASDAQ exchange.

What is LFST's market cap?

LifeStance Health Group, Inc. has a market capitalization of $2.82 billion, making it a mid-cap company.

Does LFST pay dividends?

No, LifeStance Health Group, Inc. does not currently pay a dividend to shareholders.